As a result, significant differences of 19 metabolites (2 acylcarnitines, 1 lyso-PCs, 12 PCs, and 4 amino acids) and 17 metabolites (5 acylcarnitines, 2 lyso-PCs, 7 PCs, and 3 amino acids) were found among the Hp level groups from the remaining 177 metabolites in T2DM patients and non-DM subjects, respectively (P < 0.05) (Table 2). The gene discussed is HP; the disease is diabetes mellitus.